latest news stock values companies glp-1 obesity cardiometabolic Antagonists Increase Plan Drug Spend - What's Next Outlook for obesity in 2025:

Microdosing tirzepatide uses GLP-1 and GIP signaling to support metabolic stability, steadier energy, and a more comfortable treatment experience.

Unflavored Collagen Peptides Powder is a versatile supplement designed to support skin, joint, and gut health

Novo Nordisk's semaglutide patents expire between 2026-2033 depending on formulation and jurisdiction

If your diabetes is well managed, you may be able to donate blood safely.

PrecisionLife and Ovation are developing a test to predict GLP-1 drug response, enabling precision prescribing and sustainable access to these therapies.

Compare 10 best patient check-in software platforms in 2026